股价暴涨730%的Biotech

药智网
20 Jul

细胞疗法正逐渐成为攻克癌症的重要手段之一。近日,MiNK Therapeutics公司宣布其异体iNKT细胞疗法agenT-797在治疗转移性睾丸癌和胃癌方面取得重要进展,并在权威期刊《Oncogene》上发表了相关研究成果。这一消息犹如一颗重磅炸弹,瞬间引发了市场的强烈关注,公司股价在当日收盘时暴涨730%,报收于每股64.17美元。MiNK Therapeutics的这一成果,无疑是细胞疗法...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10